GDF15 and metabolic dysfunction-associated steatotic liver disease: In conclusion, in patients with NAFLD and T2DM, GDF-15 concentrations predicted both ≥F2 and ≥F3 liver VCTE determined fibrosis, and GDF-15 concentrations may be involved in the association between T2DM and liver fibrosis in NAFLD.